NasdaqGS - Nasdaq Real Time Price USD
Recursion Pharmaceuticals, Inc. (RXRX)
5.49
+0.92
+(20.13%)
At close: June 6 at 4:00:00 PM EDT
5.57
+0.08
+(1.46%)
After hours: June 6 at 7:59:32 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-388,831
-359,174
-287,780
-83,524
-158,614
Investing Cash Flow
259,442
260,059
-10,228
193,249
-271,744
Financing Cash Flow
330,750
304,120
140,133
154,345
458,540
End Cash Position
507,511
603,024
401,425
559,112
295,349
Interest Paid Supplemental Data
--
--
96
55
680
Capital Expenditure
-12,224
-17,045
-12,552
-37,359
-39,798
Issuance of Capital Stock
330,568
300,417
128,093
143,711
462,901
Issuance of Debt
--
--
--
0
0
Repayment of Debt
-6,461
-4,440
-766
-90
-12,798
Free Cash Flow
-401,055
-376,219
-300,332
-120,883
-198,412
12/31/2021 - 4/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LYEL Lyell Immunopharma, Inc.
12.76
+11.34%
LYRA Lyra Therapeutics, Inc.
24.28
-4.15%
PHAT Phathom Pharmaceuticals, Inc.
8.92
+90.19%
SMMT Summit Therapeutics Inc.
20.59
+4.36%
VERA Vera Therapeutics, Inc.
22.70
-25.89%
CRSP CRISPR Therapeutics AG
41.86
+8.53%
BNTX BioNTech SE
108.49
-1.51%
CLRB Cellectar Biosciences, Inc.
0.3608
-11.59%
MRNA Moderna, Inc.
27.46
+5.13%
EYEN Eyenovia, Inc.
4.8800
+55.41%